Onconews

By onconews

Podcast do portal onconews.com.br

destinado a oncologistas e médicos de outras especialidades envolvidos na prevenção, no diagnóstico e no tratamento do câncer.... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Onconews:

How many episodes does Onconews have?

The podcast currently has 141 episodes available.

Onconews episodes:

May 03, 2023 Rastreamento ajustado por raça e etnia e ensaio genômico na doença ERBB2-positivo após QT neoadjuvante
Referências:
Chen T, Kharazmi E, Fallah M. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Netw Open. 2023;6(4):e238893. doi:10.1001/jamanetworkopen.2023.8893 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2803948
Bueno-Muiño C, Echavarría I, López-Tarruella S, et al. Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab. JAMA Oncol. Published online April 27, 2023. doi:10.1001/jamaoncol.2023.0187 https://jamanetwork.com/journals/jamaoncology/article-abstract/2804134

--
...more
23min
April 26, 2023Resposta patológica completa e prognóstico após QT Neo + terapia anti-HER2 no câncer de mama inicial HER2+
Referências:
van Mackelenbergh MT, Loibl S, Untch M, Buyse M, Geyer CE
Jr, Gianni L, Schneeweiss A, Conte P, Piccart M, Bonnefoi H, Jackisch C,
Nekljudova V, Tang G, Valagussa P, Neate C, Gelber R, Poncet C, Squifflet P,
Saad ED, Heinzmann D, Denkert C, Rastogi P, Cortes J, Guarneri V, de Azambuja
E, Cameron D, Ismael G, Wolmark N, Cortazar P.

Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant
Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human
Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. J Clin Oncol. 2023 Apr
19:JCO2202241. doi: 10.1200/JCO.22.02241. Epub ahead of print. PMID:
37075276. https://ascopubs.org/doi/abs/10.1200/JCO.22.02241
__
...more
10min
April 18, 2023 Tratamento a laser vaginal em pacientes com câncer de mama sintomáticas e antraciclina-taxano na doença inicial ressecável
Referências:
1. Mension E, Alonso I, Anglès-Acedo S, et al. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in
Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary
Syndrome of Menopause: The LIGHT Randomized Clinical Trial. JAMA Netw Open.
2023;6(2):e2255697. doi:10.1001/jamanetworkopen.2022.55697 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801236
2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Anthracycline-containing
and taxane-containing chemotherapy for early-stage operable breast cancer: a
patient-level meta-analysis of 100 000 women from 86 randomised trials. Lancet.
2023 Apr 15;401(10384):1277-1292. doi: 10.1016/S0140-6736(23)00285-4.
PMID: 37061269. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00285-4/fulltext

--
...more
17min
April 14, 2023 Lidocaína peritumoral pré-cirúrgica e sobrevida no câncer de mama inicial
Referência:
Rajendra A. Badwe; Vani Parmar; Varsha Gaikwad; Sudeep Gupta et al - Effect of Peritumoral
Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast
Cancer. DOI: 10.1200/JCO.22.01966 Journal of Clinical Oncology. Published
online April 06, 2023. PMID: 37023374 https://ascopubs.org/doi/abs/10.1200/JCO.22.01966
...more
15min
April 12, 2023 Terapia sistêmica na doença HER2+ convertida em axila positiva pós-cirurgia e PET/CT vs TC no paciente metastático
Referências:
1. Weiss A, Martínez-Sáez O, Waks AG, Laws A,
McGrath M, Tarantino P, Portnow L, Winer E, Rey M, Tapia M, Prat A, Partridge AH, Tolaney SM, Cejalvo JM, Mittendorf EA, King TA. Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts. Cancer. 2023 Mar 23. doi: 10.1002/cncr.34750. Epub ahead of print. PMID: 36951169. https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.34750
2. Vogsen, M., Naghavi-Behzad, M., Harbo, F.G. et al. 2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of
response monitoring in metastatic breast cancer. Sci Rep 13, 5552 (2023). https://doi.org/10.1038/s41598-023-32727-w

--
...more
25min
April 06, 2023 Esquema alternativo de exemestano e tratamento de fertilidade e incidência de câncer de mama
Referências:
Serrano D, Gandini S, Thomas P, et al. Efficacy of Alternative Dose Regimens of
Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive
Breast Cancer: A Randomized Clinical Trial. JAMA Oncol. Published online March
23, 2023. doi:10.1001/jamaoncol.2023.0089 https://jamanetwork.com/journals/jamaoncology/article-abstract/2802824
Carolyn Cullinane, Hannah Gillan, James Geraghty, Denis Evoy, Jane Rothwell,
Damian McCartan, Enda W. McDermott, Ruth S. Prichard, Fertility treatment and
breast-cancer incidence: meta-analysis, BJS Open, Volume 6, Issue 1, February
2022, zrab149, https://doi.org/10.1093/bjsopen/zrab149 ou https://academic.oup.com/bjsopen/article/6/1/zrab149/6526446
...more
22min
March 29, 2023 Contraceptivos hormonais combinados e apenas de progestagênio e risco de câncer de mama
Referência:
Fitzpatrick D, Pirie K, Reeves
G, Green J, Beral V (2023) Combined and progestagen-only hormonal
contraceptives and breast cancer risk: A UK nested case–control study and
meta-analysis. PLoS Med 20(3): e1004188. https://doi.org/ 10.1371/journal.pmed.1004188
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004188
--
...more
25min
March 22, 2023 Canabinoides no câncer de mama e resultados de longo prazo do estudo APT
Referências:
Bimonte S, Palma G, Cascella M, Cuomo A. Phytocannabinoids in Triple Negative
Breast Cancer Treatment: Current Knowledge and Future Insights. Anticancer Res.
2023 Mar;43(3):993-1000. doi: 10.21873/anticanres.16243. PMID: 36854495. https://ar.iiarjournals.org/content/43/3/993
Sara M Tolaney, MD; Paolo Tarantino, MD; Noah Graham, MB; Nabihah Tayob, PhD;
Laia Parè, PhD; Guillermo Villacampa et al. Adjuvant paclitaxel and trastuzumab
for node-negative, HER2-positive breast cancer: final 10-year analysis of the
open-label, single-arm, phase 2 APT trial. Published: March, 2023 DOI: https://doi.org/10.1016/S1470-2045(23)00051-7 ou https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00051-7/fulltext

--
...more
24min
March 15, 2023 Estudos avaliam radioterapia no câncer de mama
Referências:
Sjöström M, Fyles A, Liu FF, McCready D, Shi W, Rey-McIntyre K, Chang SL, Feng FY, Speers CW, Pierce LJ, Holmberg E, Fernö M, Malmström P, Karlsson P. Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer. J Clin Oncol. 2023 Mar 10;41(8):1533-1540. doi: 10.1200/JCO.22.00655. Epub 2023 Jan 4. PMID: 36599119. https://ascopubs.org/doi/full/10.1200/JCO.22.00655
Hepel JT, Loap P, Fourquet A, Kirova YM. DCIS Update: Escalation or De-escalation? Boost, Fractionation, and Omission of Radiation. Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):813-816. doi: 10.1016/j.ijrobp.2022.11.010. PMID: 36822780. https://www.redjournal.org/article/S0360-3016(22)03524-6/fulltext
--
...more
25min
March 08, 2023 Risco de câncer em idosas BRCA-mutado e sobrevida em 5 anos do estudo WSG-ADAPT-TP
Referências:
Metcalfe, KA, Gronwald, J, Tung, NM, et al. The risks of cancer in older women with BRCA pathogenic variants: How far have we come? Cancer. 2023; 129( 6): 901- 907. doi:10.1002/cncr.34615ou https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.34615
Harbeck N, Nitz UA, Christgen M, Kümmel S, Braun M, Schumacher C, Kreipe HH, Gluz O et al. WSG-ADAPT investigators. De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial. J Clin Oncol. 2023 Feb 21:JCO2201816. doi: 10.1200/JCO.22.01816. Epub ahead of print. PMID: 36809046. https://ascopubs.org/doi/abs/10.1200/JCO.22.01816
...more
26min

FAQs about Onconews:

How many episodes does Onconews have?

The podcast currently has 141 episodes available.